ALZN · Alzamend Neuro, Inc.
$1.33
+0.07 (+5.56%)
At close · Jul 24
Going-concern doubt
— flagged Jul 22, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors create substantial doubt about our ability to continue as a going concern for at least one year after the date that our audited financial statements are issued.”View the 10-K filed Jul 22, 2026
Market Cap
$6.37M
Shares
4.79M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 9,688 | $1.16 | $11,238 |
| 2026-06-26 | 7,648 | $1.29 | $9,866 |
| 2026-06-25 | 9,607 | $1.37 | $13,162 |
| 2026-06-24 | 27,854 | $1.37 | $38,160 |
| 2026-06-23 | 16,671 | $1.22 | $20,339 |
| 2026-06-18 | 2,114 | $1.25 | $2,643 |
| 2026-06-17 | 12,510 | $1.27 | $15,888 |
| 2026-06-16 | 15,430 | $1.23 | $18,979 |
| 2026-06-15 | 323 | $1.21 | $391 |
| 2026-06-12 | 496 | $1.16 | $575 |
| 2026-06-11 | 1,908 | $1.16 | $2,213 |
| 2026-06-09 | 18,447 | $1.13 | $20,845 |
| 2026-06-08 | 35,680 | $1.11 | $39,605 |
| 2026-06-05 | 35,349 | $1.14 | $40,298 |
| 2026-06-04 | 36,180 | $1.15 | $41,607 |
| 2026-06-03 | 74,871 | $1.14 | $85,353 |
| 2026-06-02 | 7,285 | $1.17 | $8,523 |
| 2026-05-21 | 9,528 | $1.20 | $11,434 |
| 2026-05-20 | 299 | $1.01 | $302 |
| 2026-05-19 | 373 | $1.02 | $380 |
| 2026-05-13 | 5 | $1.02 | $5 |
| 2026-05-12 | 742 | $1.05 | $779 |
| 2026-05-11 | 4,150 | $1.07 | $4,441 |
| 2026-05-08 | 7,566 | $1.06 | $8,020 |
| 2026-05-07 | 11,046 | $1.10 | $12,151 |
| 2026-05-06 | 8,467 | $1.07 | $9,060 |
| 2026-05-05 | 590 | $1.11 | $655 |
| 2026-05-01 | 2,577 | $1.14 | $2,938 |
| 2026-04-30 | 4,312 | $1.06 | $4,571 |
| 2026-04-28 | 465 | $1.08 | $502 |
Showing 1–30 of 30 settlements